WSLHD
Skip navigation
Please use this identifier to cite or link to this item: https://wslhd.intersearch.com.au/wslhdjspui/handle/1/9307
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCastellanos-Fernandez, M. I.-
dc.contributor.authorPal, S. C.-
dc.contributor.authorArrese, M.-
dc.contributor.authorArab, J. P.-
dc.contributor.authorGeorge, Jacob-
dc.contributor.authorMendez-Sanchez, N.-
dc.date.accessioned2024-03-17T22:25:28Z-
dc.date.available2024-03-17T22:25:28Z-
dc.date.issued2023-
dc.identifier.citationClinics in Liver Disease 27(2):301-315, 2023-
dc.identifier.urihttps://wslhd.intersearch.com.au/wslhdjspui/handle/1/9307-
dc.description.abstractThe epidemiologic and demographical features of nonalcoholic fatty liver disease (NAFLD) vary significantly across countries and continents. In this review, we analyze current data regarding prevalence of NAFLD in Latin America and Caribbean and Australia and review some peculiarities found in these regions. We stress the need of greater awareness of NAFLD and the development of cost-effective risk stratification strategies and clinical care pathways of the disease. Finally, we highlight the need of effective public health policies to control the main risk factors for NAFLD.-
dc.titleNonalcoholic Fatty Liver Disease in Latin America and Australia-
dc.typeJournal Article-
dc.identifier.doihttps://dx.doi.org/10.1016/j.cld.2023.01.015-
dc.subject.keywordsNon-alcoholic Fatty Liver Disease-
dc.identifier.journaltitleClinics in Liver Disease-
dc.identifier.departmentStorr Liver Centre-
dc.contributor.wslhdGeorge, Jacob-
dc.type.studyortrialReview-
dc.type.studyortrialResearch Support, Non-U.S. Gov't-
dc.identifier.pmid37024209-
dc.identifier.facilityWestmead-
Appears in Collections:Westmead Hospital 2019 - 2024

Files in This Item:
There are no files associated with this item.


Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.